Sunscreens in the United States: Current status and future outlook

Advances in Experimental Medicine and Biology

Volumn 810, Issue , 2014, Pages 464-484

  Jou, Paul C ^a   Tomecki, Kenneth J ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; 4 DIMETHYLAMINOBENZOIC ACID 2 ETHYLHEXYL ESTER; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; AVOBENZONE; CINOXATE; DIOXYBENZONE; ECAMSULE; ENSULIZOLE; HERBACEOUS AGENT; HOMOSALATE; MERADIMATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; POLYPHENOL; SUNSCREEN; TITANIUM DIOXIDE; TRIETHANOLAMINE SALICYLATE; VITAMIN D; ZINC OXIDE; PLANT EXTRACT;

BASAL CELL CARCINOMA; CANCER RISK; CELL DAMAGE; CONTROLLED CLINICAL TRIAL (TOPIC); DNA DAMAGE; DRUG LABELING; ENVIRONMENTAL FACTOR; FOOD AND DRUG ADMINISTRATION; GRAPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MELANOMA; NON MELANOMA SKIN CANCER; NONHUMAN; PHOTOAGING; PLANT SEED; POMEGRANATE; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION EXPOSURE; RADIATION PROTECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN COLOR; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; SUNLIGHT PROTECTION; TEA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UNITED STATES; CHEMISTRY; CLASSIFICATION; GOVERNMENT REGULATION; IMMUNOLOGY; METABOLISM; RADIATION INDUCED NEOPLASM; RADIATION RESPONSE; REVIEW; SKIN; SKIN TUMOR; ULTRAVIOLET RADIATION;

DOSE-RESPONSE RELATIONSHIP, RADIATION; GOVERNMENT REGULATION; HUMANS; MELANOMA; NEOPLASMS, RADIATION-INDUCED; PLANT EXTRACTS; POLYPHENOLS; SKIN; SKIN NEOPLASMS; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VITAMIN D;

EID: 84907185335     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: None     Document Type: Chapter

References (90)

1. "Protecting your skin: the history of sunscreen." Random History.com. 28 April 2009. http://www. randomhistory.com/2009/04/28_sunscreen.html. Date accessed: 05 September 2012.
2. "Piz Buin:An inspiring brand image." Piz Buin.com. 14 April 2012. http://www.pizbuin.com/us/our-brand/our-heritage. Date accessed: 13 September 2012.
3. Afaq F, Katiyar SK. Polyphenols: skin photoprotection and inhibition of photocarcinogenesis. Mini Rev Med Chem 2011; 11:1200-15; PMID:22070679.
4. Schwarz T, Halliday GM. Photoimmunology. In: Photodermatology. Lim HW, Hönigsmann H, Hawk JLM (Eds), Informa Healthcare USA, New York, NY, USA. 2007;55-74.
5. Kullavanijaya P, Lim HW. Photoprotection. J Am Acad Dermatol 2005; 52:937-58, quiz 959-62; PMID: 15928611; http://dx.doi. Org/10.1016/j.jaad.2004.07.063.
6. Sivamani RK, Ghiya M, Maibach HI. Shedding light on sunscreens and their labels: Testing policies need to match actual use. Am J Prev Med 2010; 38:679-81; PMID:20494247; http://dx.doi.0rg/10.1016/j.amepre.2010.02.009.
7. Miyamura Y, Coelho SG, Schlenz K, Batzer J, Smuda C, Choi W, et al. The deceptive nature of UVA tanning versus modest protective effects of UVB tanning on human skin. Pigment Cell Melanoma Res 2011; 24:136-47; PMID:20979596; http://dx.doi.org/10.1111/j.l755-148X.2010.00764.x.
8. "UV Index." United States Environmental Protection Agency. 07 December 2011. www.epa.gov/sunwise/uvindex.html. Date accessed: 05 September 2012.
9. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146:283-7; PMID:20231499; http://dx.d0i.0rg/10.100l/archdermatol.2010.19.
10. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30:774-8; PMID:8176018; http://dx.doi.org/10.1016/S0190-9622(08)81509-5.
11. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012.
12. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2011.
13. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2000.
14. Jou PC, Mc Cormick TS, Baron ED. UV immune suppression and cutaneous malignancies. Expert Rev Dermatol. 2011; 6:61-74; http://dx.doi.org/10.1586/edm.10.72.
15. Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, et al. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A 2009; 106:6279-84; PMID: 19329485; http://dx.doi.org/10.1073/pnas.0812401106.
16. Baron ED. The immune system and melanoma skin cancers. In: Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas. Reichrath J (Ed.) Landes Biosciences, TX, USA. 2006;43-48.
17. Jemec GB, Holm EA. Nonmelanoma skin cancer in organ transplant patients. Transplantation 2003; 75:253-7; PMID: 12589142; http://dx.doi.org/10.1097/01.TP.0000044135.92850.75.
18. Veness MJ. Defining patients with high-risk cutaneous squamous cell carcinoma. Australas J Dermatol 2006; 47:28-33; PMID: 6405479; http://dx.doi.Org/10.llll/j.1440-0960.2006.00218.x.
19. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol 2006; 154:472-7; PMID: 16445778; http://dx.doi.org/10.1111/j.1365-2133.2005.07094.X.
20. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:177-86; PMID: 10025742; http://dx.doi.org/10.1016/S0190-9622(99)70185-4.
21. Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997; 44:1172-81; PMID:9261620.
22. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980; 124:445-53; PMID:6153101.
23. Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001; 44:837-46; PMID: 11312434; http://dx.doi.org/10.1067/mjd.2001.114594.
24. Wullaert A, Bonnet MC, Pasparakis M. NF-κ B in the regulation of epithelial homeostasis and inflammation. Cell Res 2011; 21:146-58; PMD:21151201; http://dx.doi.org/10.1038/cr.2010.175.
25. Inamdar GS, Madhunapantula SV, Robertson GP. Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail. Biochem Pharmacol 2010; 80:624-37; PMID:20450891; http://dx.doi.org/10.1016/j.bcp.2010.04.029.
26. Seité S, Fourtanier A, Moyal D, Young AR. Photodamage to human skin by suberythemal exposure to solar ultraviolet radiation can be attenuated by sunscreens: a review. Br J Dermatol 2010; 163:903-14; PMD:20977441; http://dx.doi.Org/10.1111/j.1365-2133.2010.10018.x.
27. Proietti De Santis L, Garcia CL, Balajee AS, Latini P, Pichierri P, Nikaido O, et al. Transcription coupled repair efficiency determines the cell cycle progression and apoptosis after UV exposure in hamster cells. DNARepair(Amst) 2002; 1209-23; PMD: 12509253
28. Besaratinia A, Synold TW, Chen HH, Chang C, Xi B, Riggs AD, et al. DNA lesions induced by UV Al and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci U S A 2005; 102:10058-63; PMID: 16009942; http://dx.doi.org/10.1073/pnas.0502311102.
29. Lacour JP. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 2002; 146(Suppl 61):17-9; PMID: 11966727; http://dx.doi. Org/10.1046/j.1365-2133.146.s61.5.x.
30. Zhang X, Wu RS, Fu W, Xu L, Lam PK. Production of reactive oxygen species and 8-hydroxy-2'deoxyguanosine in KB cells co-exposed to benzo[a]pyrene and UV-A radiation. Chemosphere 2004; 55:1303-8; PMID: 15081772; http://dx.doi.org/10.1016/j.chemosphere.2003.12.004.
31. Javeri A, Huang XX, Bernerd F, Mason RS, Halliday GM. Human 8-oxoguanine-DNA glycosylase 1 protein and gene are expressed more abundantly in the superficial than basal layer of human epidermis. DNA Repair (Amst) 2008; 7:1542-50; PMID: 18585103;
32. Mouret S, Baudouin C, Charveron M, Favier A, Cadet J, Douki T. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci U S A 2006; 103:13765-70; PMID: 16954188; http://dx.doi.org/10.1073/pnas.0604213103.
33. Wolber R, Schlenz K, Wakamatsu K, Smuda C, Nakanishi Y, Hearing VJ, et al. Pigmentation effects of solar-simulated radiation as compared with UVA and UVB radiation. Pigment Cell Melanoma Res 2008; 21:487-91; PMID: 18627527; http://dx.doi.org/10.1111/j.1755-148X.2008.00470.x.
34. Miyamura Y, Coelho SG, Wolber R, Miller SA, Wakamatsu K, Zmudzka BZ, et al. Regulation of human skin pigmentation and responses to ultraviolet radiation. Pigment Cell Res 2007; 20:2-13; PMID: 17250543; http://dx.doi.org/10.1111/j.1600-0749.2006.00358. X.
35. Jou PC, Feldman RJ, Tomecki KJ. UV protection and sunscreens: what to tell patients. Cleve Clin J Med 2012; 79:427-36; PMID:22660875; http://dx.doi.org/10.3949/ccjm.79a.11110.
36. Food and Drug Administration (FDA). Sunburn protection factor (SPF). http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucml06351.htm. Accessed December 28, 2011.
37. Food and Drug Administration (FDA). CFR-Code of Federal Regulations Title 21, Chapter 1, Part 352: Sunscreen drug products for over-the-counter human use. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=352. Accessed August 31, 2012.
38. Wang SQ, Lim HW. Current status of the sunscreen regulation in the United States: 2011 Food and Drug Administration's final rule on labeling and effectiveness testing. J Am Acad Dermatol 2011; 65:863-9; PMID:21821312; http://dx.doi.org/10.1016/j.jaad.2011.07.025.
39. Food and Drug Administration (FDA). Labeling and effectiveness testing; Sunscreen drug products for over-the-counter human use (final rule). Federal Register 2011. http://www.gpo.gov/fdsys/pkg/FR-2011-06-17/pdf/2011-14766.pdf. Accessed August 31, 2012.
40. Food and Drug Administration (FDA). Questions and answers: FDA announces new requirements for over-the-counter (OTC) sunscreen products marketed in the US (updated 6/23/11). http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-Counter Medicines/ucm258468.htm. Accessed August 31,2012.
41. Food and Drug Administration (FDA). FDAPress Release. FDA announces changes to better inform consumers about sunscreen: New rules give consumers more information to help reduce the risk of skin cancer, early aging (Issued June 14,2011). http://www.fda.gov/News Events/Newsroom/Press Announcements/ucm258940.htm. Accessed August 31,2012.
42. Food and Drug Administration (FDA). Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates, Federal Register 2012;77(92):27591-27593. http://www.gpo.gov/fdsys/pkg/FR-2012-05-ll/pdf72012-11390.pdf. Accessed: August 31,2012.
43. Food and Drug Administration (FDA). Revised effectiveness determination; Sunscreen drug products for over-the-counter human use (proposed rule.) Federal Register 2011. http://69.175.53.6/register/2011/jun/17/2011-14769.pdf. Accessed August 31,2011.
44. Food and Drug Administration (FDA). Sunscreen drug products for over-the-counter human use: Request for data and information regarding dosage forms (advanced notice of proposed rulemaking), Federal Register 2011). http://69.175.53.6/register/2011/jun/17/201l-14768.pdf. Accessed December 28,2011.
45. Baron ED, Fourtanier A, Compan D, Medaisko C, Cooper KD, Stevens SR. High ultraviolet A protection affords greater immune protection confirming that ultraviolet A contributes to photoimmunosuppression in humans. J Invest Dermatol 2003; 121:869-75; PMID: 14632207; http://dx.doi.org/10.1046/j.1523-1747.2003.12485.x.
46. Moyal DD, Fourtanier AM. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings. J Am Acad Dermatol 2008; 58(Suppl 2):S149-54; PMID: 18410801; http://dx.doi.Org/10.1016/j.jaad.2007.04.035.
47. Boyd AS, Naylor M, Cameron GS, Pearse AD, Gaskell SA, Neldner KH. The effects of chronic sunscreen use on the histologic changes of dermatoheliosis. J Am Acad Dermatol 1995; 33:941-6; PMID:7490363; http://dx.doi.org/10.1016/0190-9622(95)90284-8.
48. Seité S, Fourtanier A, Moyal D, Young AR. Photodamage to human skin by suberythemal exposure to solar ultraviolet radiation can be attenuated by sunscreens: a review. Br J Dermatol 2010; 163:903-14; PMID:20977441; http://dx.doi.org/10.11111/j.1365-2133.2010.10018.x.
49. Young AR, Orchard GE, Harrison GI, Klock JL. The detrimental effects of daily sub-erythemal exposure on human skin in vivo can be prevented by a daily-care broad-spectrum sunscreen. J Invest Dermatol 2007; 127:975-8; PMID: 17082784; http://dx.doi.org/10.1038/sj.jid.5700606.
50. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329:1147-51; PMID:8377777; http://dx.doi.org/10.1056/NEJM199310143291602.
51. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354:723-9; PMID: 10475183; http://dx.doi.org/10.1016/S0140-6736(98)12168-2.
52. van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15:2546-8; PMID: 17132769; http://dx.doi.org/10.1158/1055-9965.EPI-06-0352.
53. Chesnut C, Kim J. Is there truly no benefit with sunscreen use and Basal cell carcinoma? A critical review of literature and the application of new sunscreen labeling rules to real world practices. J Skin Cancer. 2012;2012:480985.
54. Gallagher RP, Rivers JK, Lee TK, Bajdik CD, Mc Lean DI, Coldman AJ. Broad-spectrum sunscreen use and the development of new nevi in white children: A randomized controlled trial. JAMA 2000; 283:2955-60; PMID: 10865273; http://dx.doi.org/10.1001/jama.283.22.2955.
55. Autier P, Doré JF, Cattaruzza MS, Renard F, Luther H, Gentiloni-Silverj F, et al. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. Sunscreen use, wearing clothes, and number of nevi in 6-to 7-year-old European children. JNatl Cancer Inst 1998; 90:1873-80; PMID:9862624.
56. Dennis LK, Beane Freeman LE, Van Beek MJ. Sunscreen use and the risk for melanoma: a quantitative review. Ann Intern Med 2003; 139:966-78; PMID: 14678916.
57. Autier P. Sunscreen abuse for intentional sun exposure. Br J Dermatol 2009; 161(Suppl 3):40-5; PMID: 19775356; http://dx.doi. Org/10.1111/j.1365-2133.2009.09448.x.
58. Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29:257-63; PMID:21135266; http://dx.doi.org/10.1200/JCO.2010.28.7078.
59. Goldenhersh MA, Koslowsky M. Increased melanoma after regular sunscreen use? J Clin Oncol 2011; 29:e557-8, author reply e859; PMID:21537031; http://dx.doi.org/10.1200/JCO.2011.35.5727.
60. American Academy of Dermatology. Sunscreen Website. Stats and Facts. Prevention and Care-Sunscreens. http://www.aad.org/media-resources/stats-and-facts/prevention-and-care/sunscreens. Accessed: August 31,2012.
61. Paller AS, Hawk JL, Honig P, Giam YC, Hoath S, Mack MC, et al. New insights about infant and toddler skin: implications for sun protection. Pediatrics 2011; 128:92-102; PMID:21646256; http://dx.doi.org/10.1542/peds.2010-1079.
62. American Academy of Pediatrics. Healthy Children. Safety & prevention: Sun safety. http://www.healmychildren.org/english/safety-prevention/at-play/pages/Sun-Safety.aspx. Accessed August 31,2012.
63. Neale R, Williams G, Green A. Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch Dermatol 2002; 138:1319-25; PMID: 12374537; http://dx.doi.org/10.1001/archderm.138.10.1319.
64. Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol 2011; 91:115-24; PMID:21384086.
65. Matsuoka LY, Ide L, Wortsman J, Mac Laughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987; 64:1165-8; PMID:3033008; http://dx.doi.org/10.1210/jcem-64-6-1165.
66. Matsuoka L Y, Wortsman J, Hanifan N, Holick MF. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol 1988; 124:1802-4; PMID:3190255; http://dx.doi.org/10.1001/archderm.1988.01670120018003.
67. Marks R, Foley PA, Jolley D, Knight KR, Harrison J, Thompson SC. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Arch Dermatol 1995; 131:415-21; PMID:7726582; http://dx.doi.org/10.1001/archderm.1995.01690160043006.
68. MacLaughlin JA, Anderson RR, Holick MF. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 1982; 216:1001-3; PMID:6281884; http://dx.doi.org/10.1126/science.6281884.
69. Zeeb H, Greinert R. The role of vitamin D in cancer prevention: does UV protection conflict with the need to raise low levels of vitamin D? Dtsch Arztebl Int 2010; 107:638-43; PMID:20959891.
70. "Dietary supplement fact sheet: vitamin D." National Institutes of Health Office of Dietary Supplements. http://ods.od.nih.gov/factsheets/Vitamin D-Health Professional/. 24 June 2011. Date Accessed: 05 September 2012.
71. Simon RR, Phillips KM, Horst RL, Munro IC. Vitamin D mushrooms: comparison of the composition of button mushrooms (Agaricus bisporus) treated postharvest with UVB light or sunlight. J Agric Food Chem 2011; 59:8724-32; PMD:21736377; http://dx.doi.org/10.1021/jf201255b.
72. White PO, Tribout H, Baron ED. Protective Mechanisms of Green Tea Polyphenols in Skin. Oxid Med Cell Longev. 2012;2012:560682.
73. Silverberg JI, Jagdeo J, Patel M, Siegel D, Brody N. Green tea extract protects human skin fibroblasts from reactive oxygen species induced necrosis. J Drugs Dermatol 2011; 10:1096-101; PMID:21968658.
74. Katiyar SK, Afaq F, Perez A, Mukhtar H. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 2001; 22:287-94; PMID: 11181450; http://dx.doi.org/10.1093/carcin/22.2.287.
75. Mantena SK, Meeran SM, Elmets CA, Katiyar SK. Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. JNutr 2005; 135:2871-7; PMID: 16317135.
76. Mittal A, Piyathilake C, Hara Y, Katiyar SK. Exceptionally high protection of photocarcinogenesis by topical application of (--)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 2003; 5:555-65; PMID: 14965448.
77. Katiyar SK. Green tea prevents non-melanoma skin cancer by enhancing DNA repair. Arch Biochem Biophys 2011; 508:152-8; PMID:21094124; http://dx.doi.org/10.1016/j.abb.2010.11.015.
78. Meeran SM, Mantena SK, Elmets CA, Katiyar SK. (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res 2006; 66:5512-20; PMID: 16707481; http://dx.doi.org/10.1158/0008-5472.CAN-06-0218.
79. Bae JY, Choi JS, Choi YJ, Shin S Y, Kang SW, Han SJ, Kang YH. (-)Epigallocatechin gállate hampers collagen destruction and collagenase activation in ultraviolet-B-irradiated human dermal fibroblasts: involvement of mitrogen-activated protein kinase. Food Chem Toxicol 2008; 46:1298-307; PMID: 18226437; http://dx.doi.org/10.1016/j.fct.2007.09.112.
80. Zhao J, Wang J, Chen Y, Agarwal R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3'-gallate as the most effective antioxidant constituent. Carcinogenesis 1999; 20:1737-45; PMID: 10469619; http://dx.doi.org/10.1093/carcin/20.9.1737.
81. Mittal A, Elmets CA, Katiyar SK. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 2003; 24:1379-88; PMID: 12807737; http://dx.doi.org/10.1093/carcin/bgg095.
82. Meeran SM, Katiyar SK. Proanthocyanidins inhibit mitogenic and survival-signaling in vitro and tumor growth in vivo. Front Biosci 2008; 13:887-97; PMID: 17981597; http://dx.doi.org/10.2741/2729.
83. Vaid M, Singh T, Li A, Katiyar N, Sharma S, Elmets CA, et al. Proanthocyanidins inhibit UV-induced immunosuppression through IL-12-dependent stimulation of CD8+ effector T cells and inactivation of CD4+ T cells. Cancer Prev Res (Phila) 2011; 4.238-47; PMID.21075976; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0224.
84. Kasai K, Yoshimura M, Koga T, Arii M, Kawasaki S. Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. JNutr Sci Vitaminol (Tokyo) 2006; 52:383-8; PMID: 17190110; http://dx.doi.org/10.3177/jnsv.52.383.
85. Afaq F, Malik A, Syed D, Maes D, Matsui MS, Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol 2005; 81:38-45; PMID: 15493960; http://dx.doi.org/10.1562/2004-08-06-RA-264.1.
86. Afaq F, Zaid MA, Khan N, Dreher M, Mukhtar H. Protective effect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin. Exp Dermatol 2009; 18:553-61; PMID: 19320737; http://dx.doi.org/10.1111/j.1600-0625.2008.00829.x.
87. Afaq F, Khan N, Syed DN, Mukhtar H. Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Photochem Photobiol 2010; 86:1318-26; PMID:20946358; http://dx.doi. Org/10.llll/j.1751-1097.2010.00815.x.
88. Pacheco-Palencia LA, Noratto G, Hingorani L, Talcott ST, Mertens-Talcott SU. Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts. JAgric Food Chem 2008;56:8434-41; PMID:18717570;http://dx.doi.org/10.1021/jf8005307.
89. Lautenschlager S, Wulf HC, Pittelkow MR. Photoprotection. Lancet 2007; 370:528-37; PMID: 17693182; http://dx.doi.org/10.1016/S0140-6736(07)60638-2.
90. "FDA sheds light on sunscreens." US Food and Drug Administration. 17 May, 2012. http://www.fda.gov/forconsumers/consumerupdates/ucm258416.htm. Date accessed: 14 September, 2012.